Experienced and highly skilled senior global Medical Affairs Director with a strong background in Oncology (Pharma, Diagnostics, and Biotech). Possess strong strategic and business acumen combining an Executive MBA with a PhD. Thriving in full cross matrix regional and global roles. Developing and owning global therapy area and product strategy from early phase to product launch for US and international markets.Always provides strong analytical and strategic capabilities. Combining leadership, strategy development, medical perspective, and a commercial mindset. Constantly looking to learn and develop both on a professional and on a personal level. Oncology• lung, Melanoma, Head & Neck, Breast, Gastric, Colon, GI, Bladder and GBM• Immuno Oncology (IO)/Immuno Therapy and targeted therapy• Biomarkers, Companion and Complementary Diagnostics (CDx)• KOL interactions: Oncology, Pathology, PayersDrug Launch• Global lead in pre launch, launch and post launch teams• Strategy development from early phase to product launch (US and international)• Interactions with key external stakeholders at clinical, regulatory, health authorities and patient level• Global therapy area and product strategy development, implementation and execution at global level (US and international)• Experienced internal stakeholder management at all levels from SLT to key markets and countries